Blue Trust Inc. Lowers Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Blue Trust Inc. has reduced its holdings in HCA Healthcare by 12.3%, owning nearly 29,678 shares worth about $11.37 million after the sale.
• HCA Healthcare reported $6.84 earnings per share for the last quarter, exceeding estimates, with revenues of $18.61 billion, marking a 6.4% increase from the previous year.
• The company recently announced a quarterly dividend of $0.72 per share, representing an annualized yield of 0.7% and a dividend payout ratio of 12.11%.

Blue Trust Inc. lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,678 shares of the company's stock after selling 4,150 shares during the period. Blue Trust Inc.'s holdings in HCA Healthcare were worth $11,370,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. ORG Partners LLC boosted its position in shares of HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company's stock worth $55,000 after purchasing an additional 31 shares in the last quarter. Avantax Advisory Services Inc. grew its stake in shares of HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after acquiring an additional 32 shares during the last quarter. Glenview Trust co raised its position in shares of HCA Healthcare by 2.3% in the 1st quarter. Glenview Trust co now owns 1,451 shares of the company's stock valued at $501,000 after purchasing an additional 32 shares during the last quarter. Horizon Investments LLC increased its stake in HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after purchasing an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC lifted its stake in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after buying an additional 33 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 1.9%

NYSE:HCA opened at $418.35 on Friday. The firm has a market cap of $97.89 billion, a P/E ratio of 17.59, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. The stock has a 50 day moving average of $403.96 and a two-hundred day moving average of $375.04. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the prior year, the company earned $5.50 EPS. HCA Healthcare's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.30% of the company's stock.

Analyst Ratings Changes

A number of brokerages have commented on HCA. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Morgan Stanley dropped their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and set a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday. UBS Group set a $465.00 target price on shares of HCA Healthcare in a report on Wednesday. Finally, Royal Bank Of Canada cut their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $422.31.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.